Ausgabe 2/2021
Inhalt (30 Artikel)
Body composition and breast cancer risk and treatment: mechanisms and impact
- Review
Toshiaki Iwase, Xiaoping Wang, Tushaar Vishal Shrimanker, Mikhail G. Kolonin, Naoto T. Ueno
Meta-analysis and cost-effectiveness of ductoscopy, duct excision surgery and MRI for the diagnosis and treatment of patients with pathological nipple discharge
- Open Access
- Review
M. D. Filipe, S. I. S. Patuleia, M. R. Vriens, P. J. van Diest, A. J. Witkamp
Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review
- Review
Lua Jafari, Nausheen Akhter
Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells
- Preclinical study
Elena E. Tzekaki, George Geromichalos, Sophia N. Lavrentiadou, Maria P. Tsantarliotou, Anastasia A. Pantazaki, Angelos Papaspyropoulos
FOXA1 is a determinant of drug resistance in breast cancer cells
- Open Access
- Preclinical study
Uttom Kumar, Anastasia Ardasheva, Zimam Mahmud, R. Charles Coombes, Ernesto Yagüe
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
- Open Access
- Preclinical study
Peng Qi, Yu Yang, Qian-ming Bai, Tian Xue, Min Ren, Qian-lan Yao, Wen-tao Yang, Xiao-yan Zhou
Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy?
- Preclinical study
Ghada Aldosary, Jean-Michel Caudrelier, Angel Arnaout, Lynn Chang, Tabitha Tse, Claire Foottit, Jiheon Song, Jason Belec, Eric Vandervoort
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development
- Preclinical study
Ayako Nakashoji, Tetsu Hayashida, Shigeo Yamaguchi, Yuko Kawai, Masayuki Kikuchi, Takamichi Yokoe, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Yuko Kitagawa
Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer
- Preclinical study
Joselina Magali Mondaca, Ana Carla Castro Guijarro, Marina Inés Flamini, Angel Matias Sanchez
Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients
- Preclinical study
David W. Dodington, Andrew Lagree, Sami Tabbarah, Majid Mohebpour, Ali Sadeghi-Naini, William T. Tran, Fang-I Lu
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry
- Preclinical study
Evelyn M. Jiagge, Peter J. Ulintz, Shukmei Wong, Sean P. McDermott, Sabrina I. Fossi, Tahra K. Suhan, Mark J. Hoenerhoff, Jessica M. Bensenhaver, Barbara Salem, Michele Dziubinski, Joseph K. Oppong, Francis Aitpillah, Kyei Ishmael, Ernest Osei-Bonsu, Ernest Adjei, Awuah Baffour, Jessica Aldrich, Ahmet Kurdoglu, Kurt Fernando, David W. Craig, Jeff M. Trent, Jun Li, Dhananjay Chitale, Lisa A. Newman, John D. Carpten, Max S. Wicha, Sofia D. Merajver
Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast
- Preclinical study
Libo Yang, Madhuchhanda Roy, Heather Lin, Yu Shen, Constance Albarracin, Lei Huo, Hui Chen, Bing Wei, Isabelle Bedrosian, Hong Bu, Yun Wu
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials
- Open Access
- Clinical trial
Matthew P. Goetz, Meena Okera, Hans Wildiers, Mario Campone, Eva-Maria Grischke, Luis Manso, Valérie A. M. André, Nadia Chouaki, Belén San Antonio, Masakazu Toi, George W. Sledge Jr.
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation
- Clinical trial
Molly B. Moravek, Rafael Confino, Angela K. Lawson, Kristin N. Smith, Ralph R. Kazer, Susan C. Klock, William J. Gradishar, Jacqueline S. Jeruss, Mary Ellen Pavone
CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled study
- Open Access
- Clinical trial
Ya A. Shliakhtunou
New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12)
- Clinical trial
Jae Sik Kim, Kyubo Kim, Wonguen Jung, Kyung Hwan Shin, Seock-Ah Im, Hee-Jun Kim, Yong Bae Kim, Jee Suk Chang, Jee Hyun Kim, Doo Ho Choi, Yeon Hee Park, Dae Yong Kim, Tae Hyun Kim, Byung Ock Choi, Sea-Won Lee, Suzy Kim, Jeanny Kwon, Ki Mun Kang, Woong-Ki Chung, Kyung Su Kim, Won Sup Yoon, Jin Hee Kim, Jihye Cha, Yoon Kyeong Oh, In Ah Kim
Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI
- Clinical trial
Su Min Ha, Jung Min Chang, Soo-Yeon Kim, Su Hyun Lee, Eun Sil Kim, Yeon Soo Kim, Nariya Cho, Woo Kyung Moon
Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature
- Clinical trial
Ching-Shui Huang, Tzu-Pin Lu, Chih-Yi Liu, Chi-Jung Huang, Jen-Hwey Chiu, Yen-Jen Chen, Ling-Ming Tseng, Chi-Cheng Huang
Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer
- Clinical trial
G. F. P. Aleixo, H. Yu, Y. T. Chen, K. A. Nyrop, R. J. Louie, A. M. Deal, S. S. Shachar, H. B. Muss, G. R. Williams
International variation in breast cancer incidence and mortality in young women
- Epidemiology
Victoria Sopik
Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset
- Epidemiology
Swati Sakhuja, April Deveaux, Lauren E. Wilson, Neomi Vin-Raviv, Dongyu Zhang, Dejana Braithwaite, Sean Altekruse, Tomi Akinyemiju
COVID-19 and breast cancer at a Regional Breast Centre: our flexible approach during the pandemic
- Zur Zeit gratis
- COVID-19
- Epidemiology
Lina Cadili, Kristin DeGirolamo, Elaine McKevitt, Carl J. Brown, Christopher Prabhakar, Jin-Si Pao, Carol Dingee, Amy Bazzarelli, Rebecca Warburton
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach
- Epidemiology
Andrea P. Damin, Maira Zancan, Marcia P. Melo, Jorge V. Biazus
Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer
- Epidemiology
Ipshita Prakash, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Terry Hyslop, Oluwadamilola M. Fayanju
Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes
- Epidemiology
Sasha R. Halasz, Thomas O’Keefe, Anne M. Wallace, Sarah L. Blair
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer
- Epidemiology
Eric Xie, Maya M. Lapinski, Sarah Talamantes, Bareng A. S. Nonyane, Maria Cristina Figueroa Magalhães, Kala Visvanathan, Antonio C. Wolff, Cesar A. Santa-Maria
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
- Open Access
- Brief Report
Jasmine Sukumar, Mahmoud Kassem, Doreen Agnese, Robert Pilarski, Bhuvaneswari Ramaswamy, Kevin Sweet, Sagar Sardesai
(Ex-)breast cancer patients with (pre-existing) symptoms of anxiety and/or depression experience higher barriers to contact health care providers during the COVID-19 pandemic
- Open Access
- COVID-19
- Brief Report
Dieuwke R. Mink van der Molen, Claudia A. Bargon, Marilot C. T. Batenburg, Roxanne Gal, Danny A. Young-Afat, Lilianne E. van Stam, Iris E. van Dam, Femke van der Leij, Inge O. Baas, Miranda F. Ernst, Wiesje Maarse, Nieke Vermulst, Ernst J. P. Schoenmaeckers, Thijs van Dalen, Rhodé M. Bijlsma, Annemiek Doeksen, Helena M. Verkooijen
RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients
- Letter to the Editor
Xiao‑Min Li, Hong-Lin Chen
Correction to: Behavior of metastatic breast cancer according to subtype
- Correction
Margot Van Mechelen, Anke Van Herck, Kevin Punie, Ines Nevelsteen, Ann Smeets, Patrick Neven, Caroline Weltens, Sileny Han, Adriaan Vanderstichele, Giuseppe Floris, Jean-Pierre Lobelle, Hans Wildiers